Patents by Inventor Niv Steven MASTBOIM

Niv Steven MASTBOIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MARKERS FOR DIAGNOSING INFECTIONS
    Publication number: 20240103001
    Abstract: A method of classifying an infectious disease in a subject are disclosed. The method comprises: (a) measuring the amount of at least one protein set forth in Table 4 and at least one protein set forth in Table 6 in a sample derived from the subject; and (b) ruling in or ruling out a viral disease based on the amount of the at least one protein set forth in Table 4 and determining the severity of the viral disease based on the amount of the at least one protein set forth in Table 6.
    Type: Application
    Filed: January 18, 2022
    Publication date: March 28, 2024
    Applicant: MeMed Diagnostics Ltd.
    Inventors: Michal ROSENBERG, Oded SHAHAM, Einav SIMON, Roy NAVON, Alon ANGEL, Niv Steven MASTBOIM, Eran EDEN, Kfir OVED
  • Methods of prognosis and treatment
    Patent number: 11921119
    Abstract: A method of determining a management course for treating a subject showing symptoms of a disease is disclosed. The method comprises measuring the TRAIL protein level in a blood sample of the subject, wherein when the TRAIL level is above a predetermined amount, the subject is treated as a low-risk patient.
    Type: Grant
    Filed: October 22, 2020
    Date of Patent: March 5, 2024
    Assignee: MeMed Diagnostics Ltd.
    Inventors: Niv Steven Mastboim, Tanya Michelle Gottlieb, Kfir Oved, Eran Eden
  • RNA MARKERS FOR DIAGNOSING INFECTIONS
    Publication number: 20240026449
    Abstract: Methods of determining infection type are disclosed based on the amount of CD177 RNA and the amount of IFI44L RNA in a sample obtained from the subject. Additional RNA markers for determining infection type are also disclosed. Kits capable of determining infection type are also disclosed.
    Type: Application
    Filed: April 8, 2021
    Publication date: January 25, 2024
    Applicant: MeMed Diagnostics Ltd.
    Inventors: Oded SHAHAM, Niv Steven MASTBOIM, Oren ZARCHIN, Roy NAVON, Eran EDEN, Kfir OVED
  • METHODS OF DIAGNOSING AND CLASSIFYING VIRAL INFECTIONS
    Publication number: 20230094142
    Abstract: A method of classifying the severity of a coronaviral infection of a subject is disclosed. The method comprises measuring the TRAIL and/or IP10 protein level in a body liquid sample of the subject, wherein the level is indicative of the severity of the coronaviral infection. Managing treatments for coronaviral infections are also disclosed as well as measuring contagiousness of infections.
    Type: Application
    Filed: January 29, 2021
    Publication date: March 30, 2023
    Applicant: MeMed Diagnostics Ltd.
    Inventors: Niv Steven MASTBOIM, Oded SHAHAM, Roy NAVON, Tahel ILAN BER, Shaul LEV, Eran BARASH, Tanya Michelle GOTTLIEB, Meital PAZ, Olga BOICO, Kfir OVED, Eran EDEN
  • METHODS OF RISK ASSESSMENT AND DISEASE CLASSIFICATION
    Publication number: 20220326238
    Abstract: A method of measuring risk assessment in a patient with appendicitis is disclosed. The method comprises: (a) measuring the TRAIL protein level in a blood sample of the patient; and (b) providing a risk assessment based on the TRAIL protein level.
    Type: Application
    Filed: June 5, 2022
    Publication date: October 13, 2022
    Applicant: MeMed Diagnostics Ltd.
    Inventors: Kfir OVED, Eran EDEN, Assaf COHEN-DOTAN, Roy NAVON, Niv Steven MASTBOIM, Olga BOICO, Meital PAZ
  • Methods of risk assessment and disease classification for appendicitis
    Patent number: 11353456
    Abstract: A method of measuring risk assessment in a patient with appendicitis is disclosed. The method comprises: (a) measuring the TRAIL protein level in a blood sample of the patient; (b) providing a risk assessment based on the TRAIL protein level.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: June 7, 2022
    Assignee: MeMed Diagnostics Ltd.
    Inventors: Kfir Oved, Eran Eden, Assaf Cohen-Dotan, Roy Navon, Niv Steven Mastboim, Olga Boico, Meital Paz
  • METHODS OF PROGNOSIS AND TREATMENT
    Publication number: 20210247405
    Abstract: A method of determining a management course for treating a subject showing symptoms of a disease is disclosed. The method comprises measuring the TRAIL protein level in a blood sample of the subject, wherein when the TRAIL level is above a predetermined amount, the subject is treated as a low-risk patient.
    Type: Application
    Filed: October 22, 2020
    Publication date: August 12, 2021
    Applicant: MeMed Diagnostics Ltd.
    Inventors: Niv Steven MASTBOIM, Tanya Michelle GOTTLIEB, Kfir OVED, Eran EDEN
  • METHODS OF RISK ASSESSMENT AND DISEASE CLASSIFICATION
    Publication number: 20190242894
    Abstract: A method of measuring risk assessment in a patient is disclosed. The method comprises: (a) measuring the TRAIL protein level in a blood sample of the patient; (b) measuring the level of at least one disease-associated parameter in the patient; and (c) providing a risk assessment based on the combination of said TRAIL protein level and said disease-associated parameter level.
    Type: Application
    Filed: September 27, 2017
    Publication date: August 8, 2019
    Inventors: Kfir OVED, Eran EDEN, Assaf COHEN-DOTAN, Roy NAVON, Niv Steven MASTBOIM, Olga BOICO, Meital PAZ